Sales & Marketing News | pharmaphorum

News

Sobi sizes up $1.7bn merger with blood cancer biotech CTI

Swedish Orphan Biovitrum (Sobi) has agreed a $1.7 billion merger deal to acquire CTI BioPharma and its recently-approved Vonjo drug for people with blood cancer myelofibro

News

Gilead emerges victorious from HIV PrEP patent trial

A US court has sided with Gilead Sciences in a dispute with the US government centred on the use of HIV medicines for pre-exposure prophylaxis.

News

Farxiga back on level pegging in heart failure

The FDA has approved AstraZeneca’s SGLT2 inhibitor Farxiga as a treatment candidate for all patients with heart failure, putting the drug back in contention with rival Jar

News

FDA kicks off review of Roche’s Vabysmo in RVO

Roche could be just months away from a third indication for its eye drug Vabysmo that could accelerate its already fast growth in the US.

News

Baxter will sell biopharma unit to investors for $4.25bn

Baxter has reached an agreement to sell its contract development and manufacturing organisation (CDMO) business to a pair of private equity companies, raising $4.25 billio

News

Securing Market Access to Medicines for England, Ireland, Sc...

The PM Society Market Access Interest Group (MAIG) is gearing up to host its next in-person meeting on Tuesday, May 23rd, at the prestigious Royal Society of Medicine in London.

Sobi sizes up $1.7bn merger with blood cancer biotech CTI

Gilead emerges victorious from HIV PrEP patent trial

Farxiga back on level pegging in heart failure

FDA kicks off review of Roche’s Vabysmo in RVO

Baxter will sell biopharma unit to investors for $4.25bn

Securing Market Access to Medicines for England, Ireland, Sc...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks